Driehaus Capital Management LLC Invests $9.34 Million in Bath & Body Works, Inc. $BBWI

Key Points

• Driehaus Capital Management LLC has acquired 308,173 shares of Bath & Body Works, valued at approximately $9.34 million, amounting to about 0.14% of the company.
• Bath & Body Works recently announced a quarterly dividend of $0.20 per share, resulting in an annualized yield of 2.7%.
• Analysts have mixed views on Bath & Body Works, with a consensus rating of "Moderate Buy" and varying target prices ranging from $32.00 to $44.00.

Driehaus Capital Management LLC bought a new position in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 308,173 shares of the company's stock, valued at approximately $9,344,000. Driehaus Capital Management LLC owned about 0.14% of Bath & Body Works as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Victory Capital Management Inc. raised its position in shares of Bath & Body Works by 14,732.0% in the 1st quarter. Victory Capital Management Inc. now owns 6,798,108 shares of the company's stock worth $206,119,000 after buying an additional 6,752,274 shares during the period. Fuller & Thaler Asset Management Inc. grew its position in Bath & Body Works by 115.7% during the first quarter. Fuller & Thaler Asset Management Inc. now owns 3,680,104 shares of the company's stock valued at $111,581,000 after acquiring an additional 1,973,679 shares during the period. Assenagon Asset Management S.A. raised its holdings in shares of Bath & Body Works by 3,642.2% in the 1st quarter. Assenagon Asset Management S.A. now owns 1,651,109 shares of the company's stock worth $50,062,000 after purchasing an additional 1,606,988 shares during the period. Interval Partners LP purchased a new position in shares of Bath & Body Works in the 4th quarter worth about $37,992,000. Finally, BNP Paribas Financial Markets purchased a new position in shares of Bath & Body Works in the 4th quarter worth about $36,445,000. 95.14% of the stock is owned by hedge funds and other institutional investors.

Bath & Body Works Trading Up 4.1%

BBWI stock traded up $1.27 during midday trading on Thursday, hitting $31.83. 4,725,387 shares of the company's stock were exchanged, compared to its average volume of 5,219,291. The firm has a 50 day moving average price of $30.69 and a 200-day moving average price of $30.68. Bath & Body Works, Inc. has a 12-month low of $24.94 and a 12-month high of $41.87. The stock has a market capitalization of $6.56 billion, a price-to-earnings ratio of 9.45, a price-to-earnings-growth ratio of 0.98 and a beta of 1.49.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings results on Thursday, August 28th. The company reported $0.37 EPS for the quarter, hitting analysts' consensus estimates of $0.37. The business had revenue of $1.55 billion during the quarter, compared to the consensus estimate of $1.55 billion. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The company's revenue for the quarter was down .8% compared to the same quarter last year. During the same period last year, the firm earned $0.37 earnings per share. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. On average, sell-side analysts forecast that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 5th. Investors of record on Friday, August 22nd will be issued a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date of this dividend is Friday, August 22nd. Bath & Body Works's dividend payout ratio (DPR) is 23.74%.

Analyst Ratings Changes

BBWI has been the subject of several research reports. Piper Sandler set a $39.00 price objective on shares of Bath & Body Works and gave the stock an "overweight" rating in a research note on Thursday, May 15th. Wells Fargo & Company upped their price target on shares of Bath & Body Works from $40.00 to $44.00 and gave the stock an "overweight" rating in a research report on Wednesday, May 14th. Citigroup cut their price objective on Bath & Body Works from $42.00 to $40.00 and set a "buy" rating on the stock in a research report on Tuesday, August 19th. Wall Street Zen downgraded Bath & Body Works from a "buy" rating to a "hold" rating in a research report on Saturday, August 9th. Finally, Telsey Advisory Group reiterated an "outperform" rating and set a $38.00 target price on shares of Bath & Body Works in a report on Thursday, August 28th. Twelve equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, Bath & Body Works presently has an average rating of "Moderate Buy" and a consensus target price of $41.62.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.